Pulmonary Function Modulates Epigenetic Age in Subjects with Cystic Fibrosis. [PDF]
Castaldo A +6 more
europepmc +1 more source
Pharmacokinetic assessment of elexacaftor/tezacaftor/ivacaftor and their metabolites in maternal blood, cord blood, the neonate, and breastmilk of a cystic fibrosis carrier mother/affected fetus dyad. [PDF]
Sinkey RG +6 more
europepmc +1 more source
Cepharanthine inhibits lysosomes and induces apoptosis in triple‑negative breast cancer cells. [PDF]
Li J +5 more
europepmc +1 more source
Theratyping as a tool to guide clinical decision-making in patients with suspected cystic fibrosis and variants currently ineligible for CFTR modulator therapy. [PDF]
Gannon RM +10 more
europepmc +1 more source
Fyn-Saracatinib Complex Structure Reveals an Active State-like Conformation. [PDF]
Ta HM +5 more
europepmc +1 more source
The effects of Mixodin supplementation on migraine headache characteristics, oxidative stress and inflammatory biomarkers in patients with migraine: a double-blind, placebo-controlled, randomized trial. [PDF]
Askari MA +4 more
europepmc +1 more source
Reply to Piehler et al.: Depression Symptoms in Patients with Cystic Fibrosis Fluctuate at Baseline and Improve with Elexacaftor/Tezacaftor/Ivacaftor Therapy. [PDF]
Duff AJA, Lee TWR.
europepmc +1 more source
Impact of Elexacaftor-Tezacaftor-Ivacaftor on Quality of Life in Children With Cystic Fibrosis. [PDF]
Kümmerli S +6 more
europepmc +1 more source
Piperine protects ovarian follicles and stromal cells against doxorubicin-induced adverse effects in mouse ovaries. [PDF]
Rocha MBM +10 more
europepmc +1 more source

